Patent · US Expired

Use of protein C in the treatment of purpura fulminans

US5549893A · kind A · utility

2Cited by

2References

4Claims

0Family size

Assignee

Immuno Aktiengesellschaft · AT

Inventors

Johann Eibl · Wien, AT
Ludwig Pichler · Wien, AT
Hans-Peter Schwarz · Wien, AT

Key dates

Filing date	Apr 27, 1995
Grant date	Aug 27, 1996
Priority date	—
Expiry date	Apr 27, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is disclosed the use of protein C or activated protein C for preparing a drug useful for the maintenance and improvement of the microcirculation in patients suffering from circulatory disturbances, in particular with the proviso that the drug does not contain any immunoglobulin G.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.